Press Releases

Heart Failure (HF) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 | PRLog
www.prlog.org | Nov 10, 2011
Heart Failure (HF) Therapeutics - Pipeline Assessment and Market Forecasts to 2018. The HF Therapeutics Market Shows Significant Growth Until 2018 - PR11720407

Frost & Sullivan explores the Cardiovascular Drugs potential in KSA and UAE
www.frost.com | Apr 19, 2011
The Healthcare Practice at Frost & Sullivan, a Global Growth Partnership Company, is pleased to host an Analyst Briefing titled ‘Cardiovascular

ABB investment sharpens solar focus
www.abb.com | Mar 16, 2011
Zurich, Switzerland, March 16, 2011 – ABB, the leading power and automation technology group, has agreed to buy a 35 percent stake in Novatec Solar (formerly Novatec Biosol), an innovative Concentrated Solar Power (CSP) technology company based in Karlsruhe, Germany.

Drug Treatment for Marfan Syndrome Looks Promising, Johns Hopkins Researchers Say
www.hopkinsmedicine.org
A small study in 18 patients assessing the effectiveness of the drug losartan for treating Marfan syndrome in children has yielded encouraging results. Reporting in the June 26 issue of The New England Journal of Medicine, Johns Hopkins researchers showed that losartan-a compound used for years to

Results 1-4 of 4
 

Refine by Topic:



Refine by Content Type:

  • Refined by: Press Releases  


Refine by Source:

4 Sources ...